ASTRAZENECA PLC (AZN)
Clinical trial NCT06366451 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-04-01 → 2026-03-25 3. primary completion date: 2025-02-01 → 2026-03-25 4. enrollment: 15 → 17 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical